- Operating loss decreased vs. Q2 2019
- Net loss increased vs. Q2 2019
- ZanthoSyn® revenues increased vs. Q2 2019
- Cardax submits invited federal grant application for COVID-19 clinical trial
PR Newswire
HONOLULU, Aug. 14, 2020
PR Newswire
HONOLULU, Aug. 14, 2020
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey